These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort. Chua F; Higton AM; Colebatch AN; O'Reilly K; Grubnic S; Vlahos I; Edwards CJ; Kiely PD Rheumatology (Oxford); 2012 Oct; 51(10):1870-6. PubMed ID: 22763991 [TBL] [Abstract][Full Text] [Related]
31. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year. Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570 [TBL] [Abstract][Full Text] [Related]
33. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis. Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568 [TBL] [Abstract][Full Text] [Related]
34. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis. Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095 [TBL] [Abstract][Full Text] [Related]
35. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213 [TBL] [Abstract][Full Text] [Related]
36. Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis. Baqir M; Yi EE; Colby TV; Cox CW; Ryu JH; Specks U Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):195-201. PubMed ID: 32476954 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II. Goldin JG; Kim GHJ; Tseng CH; Volkmann E; Furst D; Clements P; Brown M; Roth M; Khanna D; Tashkin DP Ann Am Thorac Soc; 2018 Nov; 15(11):1286-1295. PubMed ID: 30265153 [TBL] [Abstract][Full Text] [Related]
38. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis. Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541 [TBL] [Abstract][Full Text] [Related]
39. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD. Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512 [TBL] [Abstract][Full Text] [Related]
40. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]